Registration opens: 15 Mar 2018, 17:00

Registration closes: 14 Jun 2018, 17:00

Closes: 14 Jun 2018, 17:00

Award: Share of €167m

Organisation: Horizon 2020

The goal of IMI, particularly in its second phase (IMI2, 2014-2020) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. Their projects will provide Europeans, including the increasing numbers of older people, with more efficient and effective medicines and treatments.

This call for proposals includes the following topics:

  • IMI2-2018-14-01: Targeted immune intervention for the management of non-response and relapse
  • IMI2-2018-14-02: Non-invasive clinical molecular imaging of immune cells
  • IMI2-2018-14-03: Development of a platform for federated and privacy-preserving machine learning in support of drug discovery
  • IMI2-2018-14-04: Centre Of Excellence – Remote Decentralised Clinical Trials

Find out more >